The global surgical hemostats, tissue sealants and adhesion barriers market estimated to be valued US$ 2,818.3 Mn in 2021 and poised to grow at significant 9.2% CAGR over 2022-2028 owing to rising geriatric population across the globe coupled with growing demand for cardiovascular, orthopedic, digestive, and other surgical procedures expected to fuel consumption of market. Moreover, well-established healthcare infrastructure, and favorable reimbursement policies fuels the growth of the market. This  report gives comprehensive outlook on surgical hemostats, tissue sealants and adhesion barriers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end-user, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, this report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global surgical hemostats, tissue sealants and adhesion barriers market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global surgical hemostats, tissue sealants and adhesion barriers products.